Pfizer’s Abrysvo has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) as the first respiratory syncytial virus (RSV) vaccine to protect both infants through maternal ...

There are also new, approved RSV vaccines available for people ages 60 and older, and for women in weeks 32 to 36 of their ...

The U.S. senator and several others sent a letter to two RSV vaccine producers, AstraZeneca and Sanofi, asking for answers about shortages and high prices.

The California Department of Public Health (CDPH) recently published an article stating, “Influenza, respiratory syncytial virus (RSV) and COVID-19 are circulating this fall, but not yet at the rate t ...

"What we'll typically see is grandma or grandpa has been babysitting their young grandchild, and now both of them are sick," ...

With respiratory virus transmission ticking up, Saint Francis Health System is hoping Tulsans take preventive measures heading into the holidays.

American pharmaceutical giant Pfizer is seeking regulatory approval in Hong Kong for its vaccine against the respiratory syncytial virus (RSV), the Post has learned, with experts saying ...

With Thanksgiving and other winter holidays on the horizon, families and friends are making plans to gather indoors for customary meals and festivities.

The U.S. Centers for Disease Control and Prevention (CDC) released more than 77,000 additional doses of Beyfortus (nirsevimab ...

Pharma's new narrative. A new generation of obesity drugs is transforming lives, dividing experts, and spurring a gigantic business battle. The science of ...

Amid an ongoing shortage of nirsevimab, an RSV immunization for young children, the CDC has announced that more than 77,000 ...

In response to a supply squeeze for Sanofi and AstraZeneca’s respiratory syncytial virus (RSV) antibody Beyfortus, the U.S. | ...